These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31344367)

  • 1. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model.
    Zhu L; Zhang Z; Hou XJ; Wang YF; Yang JY; Wu CF
    Brain Res; 2019 Nov; 1722():146344. PubMed ID: 31344367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
    Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
    Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model.
    Zhu L; Yang JY; Xue X; Dong YX; Liu Y; Miao FR; Wang YF; Xue H; Wu CF
    Mech Ageing Dev; 2015 Sep; 150():34-45. PubMed ID: 26200391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
    Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
    Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
    Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
    Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
    J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
    Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
    J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
    Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
    Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M
    Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats.
    Yin C; Deng Y; Gao J; Li X; Liu Y; Gong Q
    Neuroscience; 2016 Jul; 328():69-79. PubMed ID: 27109920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
    Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L
    Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
    Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
    Akhtar A; Bishnoi M; Sah SP
    Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation.
    Pang B; Zhang LL; Li B; Sun FX; Wang ZD
    Physiol Behav; 2023 May; 263():114134. PubMed ID: 36809844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
    Gao C; Liu Y; Jiang Y; Ding J; Li L
    Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1.
    Xu QQ; Su ZR; Hu Z; Yang W; Xian YF; Lin ZX
    Phytomedicine; 2022 Nov; 106():154441. PubMed ID: 36108371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.
    Salem MA; Budzyńska B; Kowalczyk J; El Sayed NS; Mansour SM
    Toxicol Appl Pharmacol; 2021 Oct; 429():115697. PubMed ID: 34428446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice.
    Pan D; Gu JH; Zhang J; Hu Y; Liu F; Iqbal K; Cekic N; Vocadlo DJ; Dai CL; Gong CX
    J Alzheimers Dis; 2021; 81(1):273-286. PubMed ID: 33814439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.